Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close ...
AOL

Moderna Stock is Soaring. Is It Too Late to Buy?

Moderna (NASDAQ: MRNA) is best known for its coronavirus vaccine, a product that generated more than $18 billion in revenue at its peak in 2022 and helped drive the stock higher during the early days ...

Moderna stock whipsaws as investors monitor hantavirus outbreak

Moderna stock climbed after the deadly hantavirus outbreak drew investors' attention to the company's ongoing infectious ...

Stock market today: Dow, Nasdaq futures fall as Trump rejects 'totally unacceptable' Iran peace proposal—Micron, Moderna in focus (updated)

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the story. U.S. stock futures ...
Seeking Alpha

Moderna: The Case For Staying On The Sidelines

Moderna remains a 'Sell' as the stock prices in near-perfect execution across its late-stage pipeline and oncology ambitions. The recent FDA reversal for mRNA-1010 and a $2.25B patent settlement offer ...